...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith BIO CEO & Investor Conference 2017 Slides

NBB - My money is on option 4 before year end

tada

Share
New Message
Please login to post a reply